Latest Approved Therapies for Metastatic Melanoma: What Comes Next?

Nowadays, oncogene-directed therapy and immunotherapy represent the two most promising avenues for patients with metastatic melanoma. The recent oncogene-directed therapeutic, vemurafenib, usually produces high level of tumor shrinkage and survival benefits in many patients with B-RA mutant melanoma...

Full description

Bibliographic Details
Main Author: Farid Menaa
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Journal of Skin Cancer
Online Access:http://dx.doi.org/10.1155/2013/735282

Similar Items